Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 216-220

  Vargas, Roberto ^a,b   Rauh Hain, J Alejandro ^a   Clemmer, Joel ^a   Clark, Rachel M ^a   Goodman, Annekathryn ^a   Growdon, Whitfield B ^a   Schorge, John O ^a   Del Carmen, Marcela G ^a   Horowitz, Neil S ^b   Boruta, David M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Endometrial neoplasms; Lymph node excision

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LOW RISK PATIENT; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOMETRIUM; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR INVASION; UTERUS CANCER;

ENDOMETRIAL NEOPLASMS; LYMPH NODE EXCISION;

AGED; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MYOMETRIUM; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SEER PROGRAM; TUMOR BURDEN;

EID: 84899654500     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.011     Document Type: Article

References (23)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA: Cancer J Clin 63 2013 11 30
2. J.H. Liu, B.E. Greer, and J. Curtin ACOG Practice Bulletin# 65: management of endometrial cancer Obstet Gynecol 107 2006 952 953
3. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study Cancer 60 1987 2035 2041
4. A. Mariani, M.J. Webb, G.L. Keeney, M.G. Haddock, G. Calori, and K.C. Podratz Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182 2000 1506 1519
5. M.M. AlHilli, K.C. Podratz, S.C. Dowdy, J.N. Bakkum-Gamez, A.L. Weaver, and M.E. McGree et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer Gynecol Oncol 128 2013 294 299
6. P.A. Convery, L.A. Cantrell, N. Di Santo, G. Broadwater, S.C. Modesitt, and A.A. Secord et al. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma Gynecol Oncol 123 2011 65 70
7. S. Kang, Y. Todo, T. Odagiri, T. Mitamura, H. Watari, and J.-W. Kim et al. A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer Gynecol Oncol 129 2013 33 37
8. A. Mariani, S.C. Dowdy, W.A. Cliby, B.S. Gostout, M.B. Jones, and T.O. Wilson et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging Gynecol Oncol 109 2008 11 18
9. W. Lowery, P. Gehrig, E. Ko, A. Alvarez-Secord, J. Chino, and L. Havrilesky Surgical staging for endometrial cancer in the elderly: is there a role for lymphadenectomy? Gynecol Oncol 120 2011 S94 S95
10. P.B. Panici, S. Basile, F. Maneschi, A.A. Lissoni, M. Signorelli, and G. Scambia et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
11. H. Kitchener, A. Swart, Q. Qian, C. Amos, and M. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125
12. J.K. Chan, M.K. Cheung, W.K. Huh, K. Osann, A. Husain, and N.N. Teng et al. Therapeutic role of lymph node resection in endometrioid corpus cancer Cancer 107 2006 1823 1830
13. J.K. Chan, H. Wu, M.K. Cheung, J.Y. Shin, K. Osann, and D.S. Kapp The outcomes of 27,063 women with unstaged endometrioid uterine cancer Gynecol Oncol 106 2007 282 288
14. M. Courtney-Brooks, J.M. Scalici, A.R. Tellawi, L.A. Cantrell, and L.R. Duska Para-aortic lymph node dissection for women with endometrial adenocarcinoma and intermediate-to high-risk tumors: does it improve survival? Int J Gynecol Cancer 24 2014 91 96
15. S. Dowdy, B. Borah, J. Bakkum-Gamez, A. Weaver, M. McGree, and L. Haas et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer Gynecol Oncol 127 2012 5 10
16. N. Graf, K. Rufibach, A. Schmidt, M. Fehr, D. Fink, and A. Baege Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies Eur J Gynaecol Oncol 34 2012 23 27
17. P.T. Soliman, M. Frumovitz, W. Spannuth, M.J. Greer, S. Sharma, and K.M. Schmeler et al. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists Gynecol Oncol 119 2010 291 294
18. J.C. Schink, D.S. Miller, J.R. Lurain, and A.W. Rademaker Tumor size in endometrial cancer Cancer 67 1991 2791 2794
19. M.R. Milam, J. Java, J.L. Walker, D.S. Metzinger, L.P. Parker, and R.L. Coleman Nodal metastasis risk in endometrioid endometrial cancer Obstet Gynecol 119 2012 286
20. C. Shah, E.B. Johnson, E. Everett, H. Tamimi, B. Greer, and E. Swisher et al. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer Gynecol Oncol 99 2005 564 570
21. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2010), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission.
22. D.S. Chi, R.R. Barakat, M. Palayekar, D. Levine, Y. Sonoda, and K. Alektiar et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology Int J Gynecol Cancer 18 2008 269 273
23. T.L. Cornelison, E.L. Trimble, and C.L. Kosary SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994 Gynecol Oncol 74 1999 350 355